Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients

Transplantation. 2022 Oct 1;106(10):e463-e464. doi: 10.1097/TP.0000000000004278. Epub 2022 Aug 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Neutralizing
  • COVID-19*
  • Humans
  • Organ Transplantation*
  • SARS-CoV-2
  • Transplant Recipients

Substances

  • Antibodies, Neutralizing
  • bebtelovimab